SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte ...

Good morning, everybody. My name is Kyahn Williamson, SVP of Investor Relations and Corporate Communications at Telix. And we're very pleased to welcome you today to our investor call and webcast to ...

Results demonstrated early signals of C-peptide preservation T1D key opinion leader, Michael J. Haller, MD, provided a recorded webinar reviewing the SAB-142 Phase 1 data MIAMI, March 10, 2026 (GLOBE ...

(MENAFN- GlobeNewsWire - Nasdaq) [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Viral Vaccine Cell Culture Media ...

CL Last 16, 1st Leg PostmortemBy Steven SmithAfter a difficult domestic period and a long trip to Turkey, Liverpool entered the first leg of this Champions League ...

West Texas Intermediate, the US marker, was down 15.1 per cent at $80.50 per barrel in New York. It had dipped as low as $79.73, a far cry from the almost four-year high of $119.48 it hit on Monday as ...

The White House said the US Navy has not escorted a ship through the Strait of Hormuz, following a now-deleted tweet by energy secretary Chris Wright claiming that it had. The mix ...

Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025 In post hoc analysis of the pivotal RESILIENT study, TONMYA produced rapid pain relief as early as Day 2 ...

IAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 March 10, 2026 1:00 PM EDTCompany ParticipantsWesley Bolsen - ...

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, United States College of Health Solutions, Arizona State University, Phoenix, United States ...

Background Gut bacteria have been implicated in a wide range of health conditions, yet their potential role in preventing and treating muscle-wasting disorders remains largely unexplored. Objective We ...